Copyright
©The Author(s) 2020.
World J Gastroenterol. Nov 21, 2020; 26(43): 6795-6809
Published online Nov 21, 2020. doi: 10.3748/wjg.v26.i43.6795
Published online Nov 21, 2020. doi: 10.3748/wjg.v26.i43.6795
Figure 3 Effect of oral administration of (-)-fenchone after treatment with pilocarpine and yohimbine, and on intestinal transit of mice.
Data expressed as mean ± standard deviation and analyzed by ANOVA, followed by Dunnet and Tukey's tests (bP < 0.01 and eP < 0.001, compared whit tween 5% tween 80) (P < 0.01 compared to the pilocarpine whit pilocarpine + (-)-fenchone group (n = 7/per group).
- Citation: Pessoa MLS, Silva LMO, Araruna MEC, Serafim CAL, Alves Júnior EB, Silva AO, Pessoa MMB, Diniz Neto H, de Oliveira Lima E, Batista LM. Antifungal activity and antidiarrheal activity via antimotility mechanisms of (-)-fenchone in experimental models. World J Gastroenterol 2020; 26(43): 6795-6809
- URL: https://www.wjgnet.com/1007-9327/full/v26/i43/6795.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i43.6795